<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37117225</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus.</ArticleTitle><Pagination><StartPage>6977</StartPage><MedlinePgn>6977</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6977</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-33011-7</ELocationID><Abstract><AbstractText>In slowly progressive type 1 diabetes mellitus (SPIDDM), the pancreas shows sustained islet inflammation, pancreatitis, pancreatic acinar cell metaplasia/dysplasia (ADM), and intraepithelial neoplasia (PanIN), a precancerous lesion. The mechanisms underlying these changes remain unclear. The presence of enterovirus (EV) encoded-capsid protein 1 (VP1) and -2A protease (2A<sup>pro</sup>) and the innate immune responses of the pancreas were studied using immunohistochemistry and in situ hybridization in 12 SPIDDM and 19 non-diabetic control pancreases. VP1, 2A<sup>pro</sup>, and EV-RNA were detected in islets and the exocrine pancreas in all SPIDDM pancreases. Innate immune receptor, melanoma differentiation-associated gene 5 (MDA5), and interferon (IFN)-beta1 were intensified in the islets of SPIDDM patients with short disease duration. However, expressions of MDA5 and IFN-beta1were suppressed in those with longer disease duration. CD3<sup>+</sup> T cell infiltration was observed in the VP1- and insulin-positive islets (insulitis) and exocrine acinar cells. CD11c<sup>+</sup> dendritic cells (DCs) in islets were scarce in long-term SPIDDM. This study showed the consistent presence of EV, suggesting an association with inflammatory changes in the endocrine and exocrine pancreas in SPIDDM. Suppressed expressions of MDA5 and IFN-beta1, as well as decreased numbers of DCs in the host cells, may contribute to persistent EV infection and induction of ADM/PanIN lesions, which may potentially provide a scaffold for pancreatic neoplasms.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fukui</LastName><ForeName>Tomoyasu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8535-008X</Identifier><AffiliationInfo><Affiliation>Division of Immunology and Molecular Medicine, Okinaka Memorial Institute for Medical Research, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Tetsuro</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4364-2527</Identifier><AffiliationInfo><Affiliation>Division of Immunology and Molecular Medicine, Okinaka Memorial Institute for Medical Research, Tokyo, Japan. tetsurou@yamanashi.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan. tetsurou@yamanashi.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimbo</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Immunology and Molecular Medicine, Okinaka Memorial Institute for Medical Research, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aida</LastName><ForeName>Kaoru</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Diabetes and Endocrinology, Kanoiwa Hospital, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3954-4983</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikawa</LastName><ForeName>Yoichi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-1524-6751</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Yasumichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7237-1183</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Toranomon Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyama</LastName><ForeName>Rikako</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5454-2660</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Kazuhiko</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4101-2975</Identifier><AffiliationInfo><Affiliation>Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeshita</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3685-9055</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yagihashi</LastName><ForeName>Soroku</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4255-774X</Identifier><AffiliationInfo><Affiliation>Department of Exploratory Medicine on Nature, Life, and Man, Toho University of Medicine, Chiba, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046790" MajorTopicYN="Y">Pancreas, Exocrine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007515" MajorTopicYN="Y">Islets of Langerhans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37117225</ArticleId><ArticleId IdType="pmc">PMC10147722</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-33011-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-33011-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kobayashi T, Itoh T, Kosaka K, Sato K. Time course of islet cell antibodies and β-cell function in non–insulin-dependent stage of type I diabetes. Diabetes. 1987;36:510–517. doi: 10.2337/diab.36.4.510.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.36.4.510</ArticleId><ArticleId IdType="pubmed">3545950</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, et al. Maleness as risk factor for slowly progressive IDDM. Diabetes Care. 1989;12:7–11. doi: 10.2337/diacare.12.1.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.12.1.7</ArticleId><ArticleId IdType="pubmed">2653752</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care. 1993;16:780–788. doi: 10.2337/diacare.16.5.780.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.16.5.780</ArticleId><ArticleId IdType="pubmed">8098691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T. Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: Slowly progressive IDDM—The clinical characteristics and pathogenesis of the syndrome. Diabetes Res. Clin. Pract. 1994;24(suppl):S95–S99. doi: 10.1016/0168-8227(94)90234-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8227(94)90234-8</ArticleId><ArticleId IdType="pubmed">7859641</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenström G, Gottsäter A, Bakhtadze E, Berger B, Sundkvist G. Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes. 2005;54(suppl 2):S68–S72. doi: 10.2337/diabetes.54.suppl_2.S68.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.54.suppl_2.S68</ArticleId><ArticleId IdType="pubmed">16306343</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie RD, Palmer J, Schloot NC, Lemmar A. Diabetes at the crossroads relevance of disease classification to pathophysiology and treatment. Diabetologia. 2016;59:13–20. doi: 10.1007/s00125-015-3789-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-015-3789-z</ArticleId><ArticleId IdType="pubmed">26498592</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A, et al. Slowly progressive type 1 diabetes mellitus: Current knowledge and future perspectives. Diabetes Metab. Syndr. Obes. 2019;12:2461–2477. doi: 10.2147/DMSO.S191007.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DMSO.S191007</ArticleId><ArticleId IdType="pmc">PMC6886592</ArticleId><ArticleId IdType="pubmed">31819572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K. GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care. 1996;19:1031. doi: 10.2337/diacare.19.9.1031a.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.19.9.1031a</ArticleId><ArticleId IdType="pubmed">8875105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, et al. Diagnostic criteria for slowly progressive insulin-dependent (type 1) diabetes mellitus of the Japan Diabetes Society. Diabetol. Int. 2015;6:1–7. doi: 10.1007/s13340-014-0199-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13340-014-0199-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, et al. Pancreatic ductal hyperplasia/dysplasia with obstructive chronic pancreatitis: An association with reduced pancreatic weight in type 1 diabetes. Diabetologia. 2016;59:865–867. doi: 10.1007/s00125-016-3867-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-3867-x</ArticleId><ArticleId IdType="pmc">PMC4779123</ArticleId><ArticleId IdType="pubmed">26820736</ArticleId></ArticleIdList></Reference><Reference><Citation>Aida K, et al. Distinct inflammatory changes of the pancreas of slowly progressive insulin-dependent (type 1) diabetes. Pancreas. 2018;47:1101–1109. doi: 10.1097/MPA.0000000000001144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPA.0000000000001144</ArticleId><ArticleId IdType="pmc">PMC6143218</ArticleId><ArticleId IdType="pubmed">30192315</ArticleId></ArticleIdList></Reference><Reference><Citation>Basturk O, et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am. J. Surg. Pathol. 2015;39:1730–1741. doi: 10.1097/PAS.0000000000000533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAS.0000000000000533</ArticleId><ArticleId IdType="pmc">PMC4646710</ArticleId><ArticleId IdType="pubmed">26559377</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Liu J, Nipper M, Wang P. Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma. Ann. Pancreat. Cancer. 2019;2:1–12. doi: 10.21037/apc.2019.06.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apc.2019.06.03</ArticleId><ArticleId IdType="pmc">PMC6746423</ArticleId><ArticleId IdType="pubmed">31528855</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichert M, Rustgi AK. Pancreatic ductal cells in development, regeneration, and neoplasia. J. Clin. Invest. 2014;121:4572–4578. doi: 10.1172/JCI57131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57131</ArticleId><ArticleId IdType="pmc">PMC3225990</ArticleId><ArticleId IdType="pubmed">22133881</ArticleId></ArticleIdList></Reference><Reference><Citation>Takita M, et al. Unique inflammatory changes in exocrine and endocrine pancreas in enterovirus-induces fulminant type 1 diabetes. J. Clin. Endocrinol. Metab. 2019;104:4282–4294. doi: 10.1210/jc.2018-02672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2018-02672</ArticleId><ArticleId IdType="pubmed">31112279</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejentsev S, Walker N, Riches D, et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 2009;324(5925):387–389. doi: 10.1126/science.1167728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1167728</ArticleId><ArticleId IdType="pmc">PMC2707798</ArticleId><ArticleId IdType="pubmed">19264985</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias Junior AG, Sampaio NG, Rehwinkel J. A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol. 2019;27(1):75–85. doi: 10.1016/j.tim.2018.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2018.08.007</ArticleId><ArticleId IdType="pmc">PMC6319154</ArticleId><ArticleId IdType="pubmed">30201512</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, et al. Enteroviral proteases: Structure, host interactions and pathogenicity. Rev. Med. Virol. 2016;26:251–267. doi: 10.1002/rmv.1883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1883</ArticleId><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 2014;88:3369–3378. doi: 10.1128/JVI.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Waisman A, Lukas D, Clausen BE, Yogev N. Dendritic cells as gatekeepers of tolerance. Semin. Immunopathol. 2017;39:153–163. doi: 10.1007/s00281-016-0583-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-016-0583-z</ArticleId><ArticleId IdType="pubmed">27456849</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlitzer A, McGovern N, Ginhoux F. Dendritic cells and monocyte-derived cells: Two complementary and integrated functional systems. Semin. Cell Dev. Biol. 2015;41:9–22. doi: 10.1016/j.semcdb.2015.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2015.03.011</ArticleId><ArticleId IdType="pubmed">25957517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Flynn CT, Hosking MP, Botten J, Whitton JL. Wild type Coxsackievirus infection dramatically alters the abundance, heterogeneity, and immune-stimulatory capacity of conventional dendritic cells in vivo. Virology. 2012;429:74–90. doi: 10.1016/j.virol.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2012.04.005</ArticleId><ArticleId IdType="pmc">PMC3358485</ArticleId><ArticleId IdType="pubmed">22551767</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen M, et al. Detection of enterovirus protein and RNA in multiple tissue from nPOD organ donors with type 1 diabetes. bioRxiv. 2018 doi: 10.1101/459347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/459347</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider DA, von Herrath MG. Potential viral pathogenic mechanism in human type 1 diabetes. Diabetologia. 2014;57:2009–2018. doi: 10.1007/s00125-014-3340-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-014-3340-7</ArticleId><ArticleId IdType="pmc">PMC4153966</ArticleId><ArticleId IdType="pubmed">25073445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd RE, Tamhankar M, Lernmark Å. Enteroviruses and type 1 diabetes: Multiple mechanisms and factors? Annu. Rev. Med. 2022;73:483–499. doi: 10.1146/annurev-med-042320-015952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042320-015952</ArticleId><ArticleId IdType="pmc">PMC9242008</ArticleId><ArticleId IdType="pubmed">34794324</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenson AB, Rosenber HS, Notkins AL. Pancreatic islet-cell damage in children with fatal viral infections. Lancet. 1980;316:354–358. doi: 10.1016/S0140-6736(80)90349-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(80)90349-9</ArticleId><ArticleId IdType="pubmed">6105486</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulis AK, et al. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin- dependent) diabetes and pancreases and hearts of infants who dies of coxsackieviral myocarditis. Diabetologia. 1990;33:290–298. doi: 10.1007/BF00403323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00403323</ArticleId><ArticleId IdType="pubmed">2376300</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia. 2009;52:1143–1151. doi: 10.1007/s00125-009-1276-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-009-1276-0</ArticleId><ArticleId IdType="pubmed">19266182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylipaasto P, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia. 2004;47:225–239. doi: 10.1007/s00125-003-1297-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-003-1297-z</ArticleId><ArticleId IdType="pubmed">14727023</ArticleId></ArticleIdList></Reference><Reference><Citation>Giroux V, Rustgi AK. Metaplasia: Tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat. Rev. Cancer. 2017;17:594–604. doi: 10.1038/nrc.2017.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2017.68</ArticleId><ArticleId IdType="pmc">PMC5998678</ArticleId><ArticleId IdType="pubmed">28860646</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A, et al. Enterovirus persistence in cardiac cells of patients with idiopathic dilated cardiomyopathy is linked to 5' terminal genomic RNA-deleted viral populations with viral-encoded proteinase activities. Circulation. 2019;139:2326–2338. doi: 10.1161/CIRCULATIONAHA.118.035966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.035966</ArticleId><ArticleId IdType="pmc">PMC6517084</ArticleId><ArticleId IdType="pubmed">30755025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski SE, Reilly AA, Collins DN, Ramsingh A. Progression or resolution of Coxsackievirus B4-inducced pancreatitis a genomic analysis: Progression or resolution of coxsackievirus B-4 induce pancreatitis a genomic analysis. J. Virol. 2004;78:8229–8237. doi: 10.1128/JVI.78.15.8229-8237.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.8229-8237.2004</ArticleId><ArticleId IdType="pmc">PMC446102</ArticleId><ArticleId IdType="pubmed">15254194</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada A, et al. Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care. 2001;24:510–515. doi: 10.2337/diacare.24.3.510.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.24.3.510</ArticleId><ArticleId IdType="pubmed">11289477</ArticleId></ArticleIdList></Reference><Reference><Citation>Apaolaza PS, et al. NPOD-Virus Group. Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes. Sci. Adv. 2021;24(7):eabd6527. doi: 10.1126/sciadv.abd6527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd6527</ArticleId><ArticleId IdType="pmc">PMC7904254</ArticleId><ArticleId IdType="pubmed">33627420</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell-Thompson ML, et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia. 2013;56:2541–2543. doi: 10.1007/s00125-013-3043-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-013-3043-5</ArticleId><ArticleId IdType="pubmed">24006089</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi K, et al. Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism. 1993;42:196–203. doi: 10.1016/0026-0495(93)90035-m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-0495(93)90035-m</ArticleId><ArticleId IdType="pubmed">7682643</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada A, et al. T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care. 1999;22:615–617. doi: 10.2337/diacare.22.4.615.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.22.4.615</ArticleId><ArticleId IdType="pubmed">10189541</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito K, Takahashi T, Yaginuma N, Iwama N. Islet morphometry in the diabetic pancreas of man. Tohoku J. Exp. Med. 1978;125:185–197. doi: 10.1620/tjem.125.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1620/tjem.125.185</ArticleId><ArticleId IdType="pubmed">358494</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, et al. Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia. 2014;57:392–401. doi: 10.1007/s00125-013-3094-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-013-3094-7</ArticleId><ArticleId IdType="pubmed">24190581</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimbo E, et al. Immunohistochemical detection of enterovirus in pancreatic tissues of patients with type 1 diabetes using a polyclonal antibody against 2A protease of Coxsackievirus. J. Diabetes Invest. 2022;13:435–442. doi: 10.1111/jdi.13700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdi.13700</ArticleId><ArticleId IdType="pmc">PMC8902398</ArticleId><ArticleId IdType="pubmed">34669264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Tanaka S, Aida K. Unique pathological changes in the pancreas of fulminant type 1 diabetes. Diabetol. Int. 2020;11:323–328. doi: 10.1007/s13340-020-00462-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13340-020-00462-6</ArticleId><ArticleId IdType="pmc">PMC7538509</ArticleId><ArticleId IdType="pubmed">33088638</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell-Thompson M, et al. Insulitis and β-cell mass in the natural history of type 1 diabetes. Diabetes. 2016;65:719–731. doi: 10.2337/db15-0779.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-0779</ArticleId><ArticleId IdType="pmc">PMC4764143</ArticleId><ArticleId IdType="pubmed">26581594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: A mechanism of accelerated β-cell failure in fulminant type 1 diabetes. Diabetes. 2009;58:2285–2291. doi: 10.2337/db09-0091.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db09-0091</ArticleId><ArticleId IdType="pmc">PMC2750208</ArticleId><ArticleId IdType="pubmed">19641142</ArticleId></ArticleIdList></Reference><Reference><Citation>Aida K, et al. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates β-cell death in fulminant type 1 diabetes. Diabetes. 2011;60:884–889. doi: 10.2337/db10-0795.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db10-0795</ArticleId><ArticleId IdType="pmc">PMC3046849</ArticleId><ArticleId IdType="pubmed">21289206</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell M, et al. Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast. Clin. Chim. Acta. 1996;256:175–188. doi: 10.1016/s0009-8981(96)06422-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0009-8981(96)06422-4</ArticleId><ArticleId IdType="pubmed">9027428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, et al. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes. 1986;35:335–340. doi: 10.2337/diab.35.3.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.35.3.335</ArticleId><ArticleId IdType="pubmed">3512344</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>